NCT04643457: An ongoing trial by UCB Biopharma SRL
This trial is completed, but has been granted a delay in reporting its results.
It must report results 1 year, 4 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04643457 |
|---|---|
| Title | A Phase I/IIA, Randomized, Placebo-Controlled, Single-Ascending Dose (Part A, Participant- and Investigator-Blind) and Repeated-Dose (Part B, Participant-, Investigator-, and Sponsor-Blind) Study to Investigate the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants (Part A) and in Study Participants With Moderate-to-Severe Atopic Dermatitis (Part B) |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 27, 2020 |
| Completion date | April 23, 2024 |
| Required reporting date | April 23, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |